Stada Arzneimittel AG - Company Profile
Powered by 
All the sales intelligence you need on Stada Arzneimittel AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Stada Arzneimittel AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Stada Arzneimittel AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
The following section provides information on Stada Arzneimittel AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Stada Arzneimittel AG's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Gunter von Au
Chairman Executive BoardMr. Gunter von Au has been the Chairman of the company since 2017. Prior to this, he served as the Chairman of CeramTec Holding GmbH; Director of Tyczka GmbH; Director of Rochling GmbH; Chief Executive Officer of Sud-Chemie AG; Chief Executive Officer of Sud-Chemie Inc; and as Head of Polymers, Specialty Chemistry, and Biochemistry Division at Wacker Chemie AG. Currently, Mr Au also serves as Director of Bayernwerk AG, Chairman of CeramTec Holding GmbH, and Director for Clariant AG.
Peter Goldschmidt
Chief Executive Officer Senior ManagementMr. Peter Goldschmidt has been the Chief Executive Officer of the company since 2018. Prior to this, he served as the President of Sandoz US and Head of North America for Sandoz. Mr. Goldschmidt has 35 years of experience in the pharmaceutical industry, including innovative, off-patent, and consumer healthcare medicines.
Boris Dobler
Chief Financial Officer Senior ManagementMr. Boris Dobler has been the Chief Financial Officer of the company since 2023. Prior to this, he served as the interim Group Chief Financial Officer for the company; Chief Financial Officer for European Markets of the company; and as Vice-President of Corporate Financial Planning & Analysis for the company. Mr. Dobler has also served as Chief Financial Officer for the Benelux & Nordics cluster at Teva Pharmaceutical; Chief Financial Officer of the EMEA Region for the PGT Healthcare OTC; Head of Western Europe OTC/Personal Healthcare business unit in P&G; Group Finance Manager of P&G Pharmaceuticals; Chief Operating Officer and Chief Financial Officer of Allgau Fleisch; and as Financial Analyst and Manager at Procter & Gamble.
Simone Berger
Chief Human Resources Officer Senior ManagementMs. Simone Berger has been the Chief Human Resources Officer of the company since 2021. Previously, she served as the Head of Global Human Resources of the company.
Miguel Pagan Fernandez
Chief Technical Officer Senior ManagementMr. Miguel Pagan Fernandez has been the Chief Technical Officer of the company since 2018. Prior to this, he served as the Head of Global Technical Operations at Sandoz and as Global Head of Solids & Special Tech at Novartis. Mr. Fernandez has also served as Vice President of Americas Operations at Merck & Co. (Merck Sharp & Dohme). He has more than 29 years of experience in the Pharmaceutical Industry.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer